1. Home
  2. OCUL vs UVV Comparison

OCUL vs UVV Comparison

Compare OCUL & UVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • UVV
  • Stock Information
  • Founded
  • OCUL 2006
  • UVV 1886
  • Country
  • OCUL United States
  • UVV United States
  • Employees
  • OCUL N/A
  • UVV N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • UVV Farming/Seeds/Milling
  • Sector
  • OCUL Health Care
  • UVV Industrials
  • Exchange
  • OCUL Nasdaq
  • UVV Nasdaq
  • Market Cap
  • OCUL 1.2B
  • UVV 1.3B
  • IPO Year
  • OCUL 2014
  • UVV N/A
  • Fundamental
  • Price
  • OCUL $7.00
  • UVV $53.19
  • Analyst Decision
  • OCUL Strong Buy
  • UVV
  • Analyst Count
  • OCUL 7
  • UVV 0
  • Target Price
  • OCUL $16.71
  • UVV N/A
  • AVG Volume (30 Days)
  • OCUL 917.6K
  • UVV 135.8K
  • Earning Date
  • OCUL 03-10-2025
  • UVV 03-04-2025
  • Dividend Yield
  • OCUL N/A
  • UVV 6.09%
  • EPS Growth
  • OCUL N/A
  • UVV 5.05
  • EPS
  • OCUL N/A
  • UVV 4.86
  • Revenue
  • OCUL $61,442,000.00
  • UVV $2,827,901,000.00
  • Revenue This Year
  • OCUL $11.40
  • UVV N/A
  • Revenue Next Year
  • OCUL $13.58
  • UVV N/A
  • P/E Ratio
  • OCUL N/A
  • UVV $10.93
  • Revenue Growth
  • OCUL 6.45
  • UVV 6.40
  • 52 Week Low
  • OCUL $4.06
  • UVV $45.19
  • 52 Week High
  • OCUL $11.78
  • UVV $59.13
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 31.92
  • UVV 51.83
  • Support Level
  • OCUL $7.14
  • UVV $52.31
  • Resistance Level
  • OCUL $7.42
  • UVV $54.00
  • Average True Range (ATR)
  • OCUL 0.37
  • UVV 0.94
  • MACD
  • OCUL -0.02
  • UVV 0.06
  • Stochastic Oscillator
  • OCUL 0.76
  • UVV 60.23

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About UVV Universal Corporation

Universal Corp is a global leaf tobacco supplier. The company procures leaf tobacco from farmers, processes it, and sells it to companies that manufacture consumer tobacco products. Universal does not manufacture or sell any consumer products itself. The company's segment includes Tobacco Operations and Ingredients Operations. It generates maximum revenue from the Tobacco Operations segment. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: